Qualitative development of the PROMIS Profile v1.0-Familial Chylomicronemia Syndrome (FCS) 28
Open Access
- 31 October 2022
- journal article
- research article
- Published by Springer Nature in Quality of Life Research
- Vol. 32 (2) , 605-614
Abstract
Purpose: Familial chylomicronemia syndrome (FCS) is a rare genetic disorder characterized by high triglyceride levels, significant disease burden, and negative impacts on health-related quality of life. This project aimed to create a PROMIS-based patient-reported outcome measure that represents valid and important concerns for patients with FCS. Methods: We reviewed the literature and data from a previous qualitative study of FCS to identify key FCS symptoms and impacts, which were mapped to PROMIS domains to create a pool of eligible items. Candidate items were reduced per expert feedback and patients with FCS completed cognitive interviews to confirm content validity and measure content. Results: Literature and qualitative data review identified ten key symptoms and 12 key impacts of FCS, including abdominal pain, fatigue, difficulty thinking, and worry about pancreatitis attacks. We identified 96 items primarily from PROMIS, supplemented with items from the Quality of Life in Neurological Disorders™ (Neuro-QoL™) and the Functional Assessment of Chronic Illness Therapy (FACIT) measurement systems. This pool was reduced to 32 candidate items, which were assessed via cognitive interviews with eight participants with FCS. Cognitive interview results and additional expert feedback led to the removal of four items and finalization of the PROMIS Profile v1.0—familial chylomicronemia syndrome (FCS) 28. Conclusions: The PROMIS Profile v1.0—familial chylomicronemia syndrome (FCS) 28 provides strong content validity for assessing quality of life among patients with FCS. The benefits of PROMIS, including norm-referenced mean values for each measure, will facilitate comparison of patients with FCS to other clinical populations.Keywords
Funding Information
- Ionis Pharmaceuticals
This publication has 25 references indexed in Scilit:
- Reduced psychological distress in familial chylomicronemia syndrome after patient support group interventionJournal of Clinical Lipidology, 2018
- The impact of lipoprotein lipase deficiency on health-related quality of life: a detailed, structured, qualitative studyOrphanet Journal of Rare Diseases, 2017
- The burden of familial chylomicronemia syndrome from the patients’ perspectiveExpert Review of Cardiovascular Therapy, 2017
- A method to create a standardized generic and condition-specific patient-reported outcome measure for patient care and healthcare improvementQuality of Life Research, 2017
- Building a better understanding of the burden of disease in familial chylomicronemia syndromeExpert Review of Clinical Pharmacology, 2016
- Which Is More Valid for Stroke Patients: Generic or Stroke-Specific Quality of Life Measures?Neuroepidemiology, 2009
- Evaluation of Item CandidatesMedical Care, 2007
- Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidanceHealth and Quality of Life Outcomes, 2006
- The F unctional A ssessment of C hronic I llness T herapy (FACIT) Measurement System: properties, applications, and interpretationHealth and Quality of Life Outcomes, 2003
- Generic and Disease-Specific Measures in Assessing Health Status and Quality of LifeMedical Care, 1989